Trinity Biotech ADR Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Trinity Biotech ADR Stock
So far the community has only identified positive things for Trinity Biotech ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Trinity Biotech ADR in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Trinity Biotech ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Trinity Biotech ADR | - | - | - | - | - | - | - |
| Avid Bioservices Inc | 0.840% | -7.031% | -4.032% | -65.805% | -2.459% | -63.720% | 56.188% |
| Rockwell Medical Inc. | 1.620% | -4.943% | -3.329% | -27.026% | -20.146% | -83.286% | -96.859% |
| Gritstone Oncology Inc | -0.790% | 1.083% | -72.441% | -70.085% | -62.325% | -90.956% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-25
Upon an initial overview of Trinity Biotech's financial statements and ratios, it's evident that the company, trading under the symbol TRIB within the pharmaceuticals industry, is facing several financial challenges. The negative total stockholder equity figures across multiple years and a net income trajectory that has been in the negative zone indicate underlying financial stress. These snapshots raise questions regarding the company's profitability, debt management, and overall financial stability.
Delving into a more detailed analysis uncovers several pros and cons:
*Pros: *
Comments
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for TRIB provided by MarketBeat
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for TRIB provided by MarketBeat
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for TRIB provided by MarketBeat